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ABSTRACT
APE1 is a multifunctional protein with a fundamen-
tal role in repairing nuclear and mitochondrial DNA
lesions caused by oxidative and alkylating agents.
Unfortunately, comprehensions of the mechanisms
regulating APE1 intracellular trafficking are still frag-
mentary and contrasting. Recent data demonstrate
that APE1 interacts with the mitochondrial import
and assembly protein Mia40 suggesting the involve-
ment of a redox-assisted mechanism, dependent on
the disulfide transfer system, to be responsible of
APE1 trafficking into the mitochondria. The MIA path-
way is an import machinery that uses a redox system
for cysteine enriched proteins to drive them in this
compartment. It is composed by two main proteins:
Mia40 is the oxidoreductase that catalyzes the for-
mation of the disulfide bonds in the substrate, while
ALR reoxidizes Mia40 after the import. In this study,
we demonstrated that: (i) APE1 and Mia40 interact
through disulfide bond formation; and (ii) Mia40 ex-
pression levels directly affect APE1’s mitochondrial
translocation and, consequently, play a role in the
maintenance of mitochondrial DNA integrity. In sum-
mary, our data strongly support the hypothesis of
a redox-assisted mechanism, dependent on Mia40,
in controlling APE1 translocation into the mitochon-
drial inner membrane space and thus highlight the
role of this protein transport pathway in the main-
tenance of mitochondrial DNA stability and cell sur-
vival.
INTRODUCTION
APE1 is themain apurinic/apyrimidinic (AP) endonuclease
in the base excision repair (BER) pathway where it plays a
central role in the maintenance of the genome stability be-
ing the only cellular protein that can process AP sites gener-
ated by DNA glycosylases (1). However, APE1 has at least
another major cellular function, since it works as a redox
signaling protein interacting with many transcriptional fac-
tors involved in cancer promotion and progression, such
as NF-B, p53, HIF-1 and more, and facilitating their
DNA binding via reduction of cysteine residues (2). These
two major functions of APE1, redox and repair, are com-
pletely independent: the N-terminus, containing a bipar-
tite nuclear localization signal (NLS), is mainly devoted to
redox-mediated activity, while the C-terminus exerts the en-
zymatic activity on the abasic sites of DNA (3). The im-
portance of APE1 function in cell survival is demonstrated
by the lethality of the APE1 gene-knockout in mice (4).
APE1’s localization is eminently nuclear although the pro-
tein is also present within the mitochondrial matrix, as an
essential component of the mitochondrial BER (mtBER)
pathway (5,6). Notably, the mechanisms regulating APE1
intracellular trafficking are still largely unknown.Adescrip-
tion of APE1 mitochondrial localization was proposed by
Chattopadhyay et al. by which proteolysis at Asn33 was re-
sponsible for the loss of NLS, therefore redirecting trun-
cated N33APE1 protein toward non-canonical subcellu-
lar compartments such as mitochondria (7). However, data
from our previous work highlight the presence of the full-
length APE1 protein within mitochondria of follicular thy-
roid cells (8). Also recent data fromour lab confirm the pres-
ence of APE1 within mitochondria in its full-length form
and that, during the trafficking from cytosol to the mito-
chondrial matrix, APE1 tends to accumulate within the in-
ner membrane space (IMS) (6). In 2011 Li et al. demon-
strated that the MTS of APE1 resides within residues 289–
318 of the C-terminus, which is masked by the N-terminal
domain, therefore suggesting the occurrence of specific and
regulatedmechanisms of protein unfolding–refolding to en-
sure proper APE1 localization (9). Data reported identified
residues Lys299 and Arg301 as critical sites which mutation
abolishes APE1 interaction with Tom20 and consequently
the mitochondrial translocation of the protein (9).
Mitochondria are the main endogenous source of Reac-
tive Oxygen Species (ROS) and, like nuclear DNA (nDNA),
the integrity of mitochondrial DNA (mtDNA) is also
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constantly threatened by exposure to different damaging
agents. Because of the association with the inner mem-
brane, close to the ROS-generating electron transport
chain, mtDNA is much more susceptible to ROS-induced
damage than genomic DNA showing 16-fold higher lev-
els of 8-oxoG formation (10). ROS-induced oxidative le-
sions and alkylated bases in DNA are repaired via BER,
the major DNA repair mechanism acting in mitochondria
(11). BER is the primary pathway known for repairing of
small helix non-distorting DNA lesions and taking place
both in the nucleus and in mitochondria, and is based on
a cascade of multiple steps. All the components of the mt-
BER pathway are nuclear encoded and imported into mi-
tochondria (12). The BER pathway includes four distinct
steps: (i) recognition and removal of the modified base op-
erated by a DNA glycosylase; (ii) processing of the gener-
ated apurinic/apyrimidinic (AP) site by APE1 protein; (iii)
incorporation of the correct nucleotide(s) through the activ-
ity of the mitochondrial polymerase  ; and (iv) nick sealing
catalyzed by the DNA ligase III.
Little is known about the mechanisms of BER induction
in mitochondria, except that in the presence of mtDNA
damage, the mtBER pathway is activated (13) and that
APE1 translocates into mitochondria in response to ox-
idative stress, increasing mtDNA repair rate and therefore
promoting cell survival (14). Due to its significant molec-
ular mass, mitochondrial localization of APE1 should re-
quire active transportation processes. The main chaperone
responsible for redox-assisted folding processes within IMS
of mitochondria in mammals is Mia40 (15). Mitochon-
drial intermembrane space import and assembly protein 40
(Mia40) and Augmenter of liver regeneration (ALR) rep-
resent the central components of the MIA import machin-
ery that uses a redox system to drive cysteine-enriched pro-
teins into the mitochondrial compartment. After the pas-
sage throughout the inner membrane via Translocase of the
outer membrane (TOM), substrate proteins are recognized
by Mia40 through a process that involves the formation of
disulfide bonds between Mia40 and the precursor protein.
Mia40 is composed of a highly conserved C-terminal do-
main, which contains the catalytic CPC (cysteine–proline–
cysteine) motif and a hydrophobic cleft. Once Mia40 has
oxidized its substrate, its CPCmotif remains in a completely
reduced form and has to be re-oxidized for a further cycle
of import (16). The protein responsible for this process is
ALR, a sulfhydryl oxidase coupled with one molecule of
Flavin Adenin Dinucleotide (FAD) that acts as a homod-
imer in solution (17–19).Mia40 is ubiquitously expressed in
human tissues and the highest levels of Mia40 were found
in the liver, brain and kidney at both transcript and protein
levels (20,21). In humanMia40, the CPCmotif is formed by
Cys53 and Cys55 residues and the cysteine responsible for
the intermolecular disulfide bond is the Cys55 (22). Muta-
tion of this cysteine residue results in the loss of function of
Mia40 that is nomore able to interact with the substrate. On
the contrary, when Cys53 is mutated, Mia40 is still able to
interact with the substrates but cannot efficiently complete
the oxidation reaction (23–25).
The majority of Mia40-dependent proteins have been
identified in yeast. Typical substrates of the MIA path-
way are small proteins, around 10 kDa, whose destination
is the IMS or the matrix. These proteins are cysteine en-
riched, belong to the families of the twin CX3C and CX9C
proteins and fulfill different functions in the mitochondria
(16,26,27). Recently, also the tumor suppressor protein p53
was found to localize within human mitochondria through
theMIA pathway. Authors demonstrated that the import is
an active process activated by oxidative stress, respiration-
dependent, and that it contributes to the maintenance of
mtDNA integrity (28).
The present study focuses on the identification and char-
acterization of the import machinery that mediates APE1
translocation into the mitochondrial compartment. Our
data identify APE1 as a new substrate of Mia40 and cor-
relate its expression with the translocation of APE1 and the
repair capacity of mtBER supporting the involvement of
the MIA pathway in controlling the mitochondrial genome
stability.
MATERIALS AND METHODS
Cell culture and treatments
HeLa and Huh7 cells were grown in DMEM (Dulbecco’s
modified Eagle’s medium), JHH6 cells were grown in
William’s medium E, both supplemented with 10% fetal
bovine serum (FBS), 100-U/ml penicillin and 10-g/ml
Streptomycin sulphate. One day before treatment HeLa
cells were seeded 4 × 106 cells/plate. For mtDNA damage
measurements HeLa and JHH6 cells were treated with 400
M and 1.2 mM of H2O2, respectively, in medium with-
out serum for 15 min, and then cells were grown for 1 h in
the presence of 10% FBS before harvesting. For cell viabil-
ity analysis 5 × 104 JHH6 and 10 × 104 Huh7 cells were
seated on 96 multiwell plates and after 24 h treated with the
reported amount of Methyl methanesulfonate (MMS) or
H2O2 for 8 h in medium without FBS. For inducible silenc-
ing of endogenous APE1, HeLa cell clones were developed
as described in Vascotto et al. (29). For inducible siRNA
experiments, doxycycline (Sigma) was added to the cell cul-
ture medium at the final concentration of 1g/ml, and cells
were grown for 10 days.
Transient transfection experiments
One day before transfection cells were seeded in 10-cm
plates at the density of 1.2× 106 cells/plate. Cells were then
transfected with 100 nM of either shRNA Mia40 scramble
(control) or shRNA Mia40 (encoding for siRNA against
Mia40) per plate usingOligofectamineReagent (Invitrogen)
according to the manufacturer’s instructions. Cells were
harvested 72 h after the transfection.
For overexpression of APE1 and Mia40 proteins, 2.5 ×
106 cells/plate were seeded 24 h before transfection. Cells
were then transfectedwith 2g of pCMV5.1APE1-FLAG,
C65S, C93S, C99S, C65S+C93S, C65S+C99S or Mia40-
HisTag per plate using Lipofectamine Reagent (Invitrogen)
according to the manufacturer’s instructions. Cells were
harvested 24 h after the transfection. For transient APE1
silencing HeLa cells were seeded at the density of 1.2 × 106
cells/plate. Then, cells were transfectedwith 6g of pSuper-
scramble or pSuper-APE1, in order to obtain silencing of
endogenous APE1, and with 6 g per plate of pCMV 5.1
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Empty, APE1WT, C65S or C93S to re-express APE1. Cells
were harvested 48 h after the transfection.
Preparation of total cell extracts and anti-Flag affinity purifi-
cation
For the preparation of total cell lysates cells were har-
vested by trypsinization and centrifuged at 250 × g for
5 min at 4◦C. Supernatant was removed, and the pellet
was washed once with ice-cold phosphate-buffered saline
(PBS) and then centrifuged again as described before. Cell
pellet was resuspended in lysis buffer [50-mM Tris HCl
(pH 7.4), 150-mMNaCl, 1-mM ethylenediaminetetraacetic
acid (EDTA), 1% [wt/vol] Triton X-100, protease inhibitor
cocktail (Sigma), 0.5-mM phenylmethylsulfonyl fluoride] at
a cell density of 107 cells/ml and rotated for 30 min at 4◦C.
After centrifugation at 12 000 × g for 10 min at 4◦C, the su-
pernatant was collected as total cell lysate (WCE). The pro-
tein concentration was determined using Bio-Rad protein
assay reagent (Bio-Rad). For affinity purification analysis
total cell lysates were incubated with anti-Flag M2 affinity
gel (Sigma) for 3 h at 4◦C and then processed following the
manufacturer’s instructions. Proteinswere eluted by incuba-
tion with 0.15 mg/ml 3xFlag peptide in Tris-buffered saline
and then subjected to western blot analysis.
Preparation of subcellular fractions
Subconfluent HeLa and JHH6 cells were collected and
suspended in Grinding buffer (250-mM sucrose, 1-mg/ml
bovine serum albumin (BSA), 2-mM EDTA, pH 7.4) with
1:100 protease inhibitor cocktail. Cell suspensions were
sonicated on ice undermild controlled conditions to disrupt
selectively plasma membranes (4-s sonication one time).
The homogenates were then fractionated by differential
centrifugation at 800 × g and 16 000 × g at 4◦C, to ob-
tain the enriched cytoplasmic, nuclear and mitochondrial
fractions. Samples were then subjected to Bradford analysis
for the evaluation of protein content before separation on
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and western blot analysis. Purity of mi-
tochondria and nuclei was evaluated using specific marker
proteins (LSD1 for nuclei and ATP 5A for mitochondria)
to ascertain the absence of cross contamination between the
two compartments.
Western blot analysis
The indicated amounts of total, cytoplasmic, nuclear or mi-
tochondrial extracts were electrophoresed onto a 12% SDS-
PAGE. Then, proteins were transferred to nitrocellulose
membranes (Schleicher & Schuell). Membranes were satu-
rated by incubation with 5% non-fat dry milk in PBS/0.1%
Tween 20 for 1 h at room temperature, and incubated with
the specific primary antibody [anti-APE1 monoclonal (No-
vartis): overnight 4◦C, dilution 1:2000; anti-FLAG mon-
oclonal (Sigma): 3 h at 25◦C, dilution 1:3000; anti-Actin
polyclonal (Sigma): overnight at 4◦C, dilution 1:2000; anti-
ATP 5A monoclonal (Abcam): overnight at 4◦C, dilution
1:10000; anti-LSD1 polyclonal (Abcam): overnight at 4◦C,
dilution 1:10000; anti-Mia40 polyclonal (gift from the lab-
oratory of Prof. Matthias Bauer) overnight at 4◦C, dilution
1:1000; anti-HisTag polyclonal (Sigma): overnight at 4◦C,
dilution 1:2000]. Membranes were washed three times with
PBS/0,1% Tween 20 and incubated for 2 h with the sec-
ondary antibody. After three washes with PBS/0.1% Tween
20 signals were detected with the enhanced chemilumines-
cence procedure (Bio-Rad) (Figures 1A, 2A, 3B and 4A)
or Odyssey CLx scanner (Li-Cor Biosciences) (Figures 1B
and C, 5B and C, 6A and 3A and C). Normalization was
performed with polyclonal antibodies anti-Actin for total
extracts and with ATP 5A for mitochondrial extracts. Blots
were then quantified by using aGelDoc video-densitometer
(Bio-Rad) or ImageStudio software (Li-Cor Biosciences).
DNA extraction and mtDNA damage measurement by quan-
titative PCR
After treatments cells were harvested by trypsin and high-
molecular weight DNA was isolated with the QUIAGEN
Genomic-tip 20/G and G2, QBT, QC, QF buffers (all
reagents are distributed byQiagen) as described by theman-
ufacturer. Briefly cells were resuspended in G2 buffer sup-
plemented with 400 g of RNase A and 6 mAU of pro-
teinase K and incubated at 50◦C for 2 h in a water bath.
Samples were then applied to equilibrated columns, washed
three times with QC buffer and then eluted with 1 ml of
QF buffer twice. DNAwas precipitated overnight at−80◦C
with the addition of 700 l of isopropanol and then cen-
trifuged at 4◦C, 15 000 × g for 1 h. DNA was washed with
EtOH 75%, centrifuged again and resuspended in 100 l of
Tris-EDTA buffer pH 8. Quantification of DNA was per-
formed with Quant.iT-Picogreen dsDNA reagent (Invitro-
gen) according to themanufacturer’s instructions andDNA
concentration was adjusted to 10 ng/l.
The number of mtDNA lesions was determined by
Q-PCR. The following primers were used: Mitolong for
5′-TCT AAG CCT CCT TAT TCG AGC CGA-3′ and
Mito rev 5′-TTT CAT CAT GCG GAG ATG TTG GAT
GG-3′ which amplified an 8.9-kb mitochondrial fragment;
and Mitoshort for 5′-CCC CAC AAA CCC CAT TAC
TAA ACC CA-3′ and Mito rev, which amplified a 221-bp
mitochondrial fragment. DNA was amplified using Elon-
gase enzyme mix (Invitrogen). The polymerase chain reac-
tion (PCR) was initiated at 94◦Cwith hot-start for the com-
plete denaturation of DNA and allowed to undergo the fol-
lowing thermocycler profile: an initial denaturation for 1
min at 94◦C followed by 19 cycles of 94◦C denaturation for
1min and 64◦C annealing/extension for 11min for the 8900
bp fragment and 60◦C annealing for 45 s and 72◦C exten-
sion for 45 s for the 221 bp. A final extension at 72◦C was
performed for 10 min for both fragments. To ensure quanti-
tative conditions a sample with the 50% of template amount
was included in each amplification and, as negative con-
trol, a sample without the template was used. PCRproducts
were quantified in triplicate by using Quant.iT-Picogreen
dsDNA reagent. Themitoshort fragment was needed to cal-
culate the relative amount of mtDNA copies and to nor-
malize the lesion frequencies calculated with the mitolong
fragment.
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RNA extraction and Real time-PCR
Total RNA from HeLa cells transfected with pCMV5.1
APE1 constructs was extracted with the SV Total RNA iso-
lation System kit (Promega). 1 g of total RNA was re-
verse transcribed using the iScript cDNA synthesis kit (Bio-
Rad), according to the manufacturer’s instructions. Quan-
titative reverse-transcription PCR was performed with a
CFX96Real-Time System (Bio-Rad) using iQ SYBRGreen
Supermix (Bio-Rad). Primer sequences for ectopic APE1
are: sense, 5- CAG CAA GAT CCG TTC CAA -3′; anti-
sense, 5’- TTG TCA TCG TCG TCC TTG TAA -3’. Hu-
man glyceraldehyde-3-phosphate dehydrogenase was used
as internal control.
Expression and purification of recombinant proteins
pGEX-3X expression plasmids (Sigma) containing either
wild-type APE1 or APE1 C65S, C93S, C99S, C65/93S,
C65/99S mutants or pGEX-4T expression vectors (Sigma)
containing wild-type Mia40, Mia40 C55S mutant or the
empty vector were transformed into Escherichia coli BL21
(DE3) cells (Stratagene). Bacterial cells were grown at 37◦C
to an absorbance of 0.8 OD measured at 600 nm, and then
protein expression was induced with 1-mM isopropyl--D-
thiogalactopyranoside. Induction was carried out for 4 h
for GST-APE1 and GST and for 2 h for Mia40 at 37◦C
and then cells were collected by centrifugation at 4000 ×
g for 20′ at 4◦C. Cells were resuspended in Lysis buffer (20-
mM Tris HCl (pH 8.0), 250-mM NaCl, 0.1% [v/v] Tween-
20) with protease inhibitor cocktail (Sigma), sonicated five
times for 30 s and then centrifuged at 16 000× g for 30 min.
Recombinant proteins were purified from the clarified ex-
tracts on an AKTA Prime FPLC system (GE Healthcare)
using GSTrap HP columns (GE Healthcare). To remove
the GST tag from GST–APE1, WT and mutant proteins
were further hydrolyzed with factor Xa (five factor Xa units
per milligram of recombinant GST-fused protein) for 4 h
at room temperature (RT). The protease was then removed
from the sample using a benzamidine HiTrap FF column
(GE Healthcare), and the proteins were then purified on a
GSTrap HP column to purify APE1 from the GST tag. The
quality of purification was checked by SDS-PAGE analy-
sis. Accurate quantification of all recombinant proteins was
performed by colorimetric Bradford assays (Bio-Rad) and
confirmed by SDS-PAGE (Supplementary Figures S1 and
S2).
GST pull-down assay
For GST pull-down experiments, 15 pmol of GST-Mia40
was added together with 15 pmol of APE1 WT or APE1
C65S, C93S, C99S, C65/93S, C65/99S mutants, to 10 l
of glutathione-Sepharose 4B beads (GE Healtcare). Bind-
ing was performed in Binding buffer (1 X PBS, 50-mM Tris
pH 8.0, 50% glycerol, 0.5% NP40 and protease inhibitor)
for 3 h under rotation at 4◦C. The beads were washed three
times with Washing buffer (1 X PBS, 0.1% NP40, 10% glyc-
erol and protease inhibitor). Proteins were eluted for 10
min with Elution buffer (50-mM Tris pH 8.0 and 10-mM
GSH). Then, samples were dissolved in reducing lamely
buffer (250-mM Tris-HCl pH 6.8, 8% SDS, 40%, Glyc-
erol, 0.08%Bromophenol Blue, 20%-mercaptoethanol) or
non-reducing lamely buffer (250-mM Tris-HCl pH 6.8, 8%
SDS, 40%, Glycerol, 0.08% Bromophenol Blue) and loaded
onto 12% SDS-PAGE gels followed by western blot. The
presence of APE1 and GST proteins was detected using
anti-APE1 protein monoclonal antibody and GST mono-
clonal antibody, respectively.
Endonuclease assay
Endonuclease assay was performed by carrying out enzy-
matic reactions in a final volume of 10 l. After mitochon-
drial purification, the protein content was quantified by
Bradford and 25 ng of mitochondrial protein extract was
dissolved in AP buffer (50-mM HEPES, 50-mM KCl, 10-
mM MgCl2, 1-g/ml BSA, 0.05% (w/v) Triton X-100, pH
7.5). Reactions were started by adding 100 nM of double-
stranded abasic DNA substrate obtained by annealing a
DY-782-labeled oligonucleotide [5′-AAT TCA CCG GTA
CCF TCT AGA ATT CG-3′] (Eurofins MWG Operon),
where F indicates a tetrahydrofuran residue, with the com-
plementary sequence [5′-CGA ATT CTAGAGGGTACC
GGT GAA TT-3′] and incubated at 37◦C for the reported
amount of time. Reactions were halted by the addition of
Stop solution (96% (v/v) formamide, 10-mM EDTA, Xy-
lene cianolo and bromophenol blue), separated onto a 20%
(w/v) denaturing polyacrylamide gel and analyzed on an
Odyssey CLx scanner (Li-Cor Biosciences). mtAPE1 en-
donuclease activity of control and Mia40 siRNA was mea-
sured in all five biological replicates. The percentage of
substrate converted to product was determined using the
ImageStudio software (Li-Cor Biosciences). For each time
point reported in the diagram of Figure 3C the percentage
of product formation and SDwere calculated as the average
of the biological replicates.
Proximity ligation assay (PLA)
To monitor the interaction between ectopic APE1 and en-
dogenous Mia40 in living cells, the in situ Proximity Lig-
ation Assay kit (Olink Bioscience) was used. HeLa cells
were seated into a glass coverslip in the amount of 8 ×
104 per 24 X multiwell plate, and then transiently trans-
fected with a FLAG-tagged form of APE1 WT, or mu-
tants. Twenty four hours after transfection, cells were fixed
with 4% (w/v) paraformaldehyde, permeabilized for 5 min
with Triton X-100 0.25% in PBS 1X and incubated with
5% normal fetal bovine serum in PBS-0.1% (v/v) Tween-
20 (blocking solution) for 30 min, to block unspecific bind-
ing of the antibodies. Cells were then incubated with the
mouse monoclonal anti-FLAG FITC conjugated antibody
(Sigma Aldrich) at a final dilution of 1:500 for 1 h an RT,
in a humid chamber. After washing three times with PBS-
0.1% (vol/vol) Tween-20 (washing solution) for 5 min, cells
were then incubated with a rabbit anti-Mia40 overnight at
4◦C. PLA was performed following manufacturer’s instruc-
tions. Technical controls, represented by the omission of
the anti-Mia40 primary antibodies, resulted in the com-
plete loss of PLA signal. Images were acquired using a Le-
ica TCS SP laser-scanning confocal microscope (Leica Mi-
crosystems) equipped with a 488-nm argon laser, a 543-nm
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HeNe laser and a 63X oil objective (HCX PLAPO 63X Le-
ica). At least 15 randomly selected cells per condition were
analyzed. PLA-spots present in each single cell were then
scored using the BlobFinder software (Olink Bioscience).
Anti-FLAG staining for APE1 was used to identify cell nu-
clei.
Cell viability assay
Cell viability was measured through the CellTiter 96 AQue-
ous One Solution Cell Proliferation Assay (Promega) ac-
cording to the manufacturer’s instructions.
Statistical analyses
Statistical analyses on biological data were performed us-
ing theMicrosoft Excel data analysis program for Student’s
t-test analysis. P < 0.05 was considered as statistically sig-
nificant.
RESULTS
Cys55 of Mia40 forms a mixed disulfide bond with APE1
In order to assess the interaction between APE1 and
Mia40 in an in vivo cell model, we transiently transfected
HeLa cells with pCMV 5.1 plasmids expressing Mia40-
HisTag, and APE1-FLAG (IP) or the empty vector as con-
trol (Mock). Then, APE1-FLAG was immunopurified and
Mia40-HisTag protein was detected in the IP fraction (Fig-
ure 1A). To evaluate if the interaction between the two pro-
teins involved the formation of a disulfide bond, recom-
binant Mia40 expressed in fusion with a GST tag at the
N-terminus (rGST-Mia40) (Supplementary Figure S1A)
and recombinant APE1 (rAPE1) (Supplementary Figure
S2) were produced and the interaction quantified through
GST pull-down assays. rGST-Mia40 was used as ‘bait’ and
rAPE1 was used as ‘prey’, while GST protein alone was
used as a negative control. GST pull-down samples sep-
arated in SDS-PAGE under reducing conditions demon-
strated that APE1 was able to interact with Mia40 (Figure
1B, lane 2), and incubation with a reducing agent (DTT) led
to an almost complete loss of APE1 signal in the pull-down
fraction (lane 3). To evaluate the presence of aMia40/APE1
complex, GST pull-down samples were also separated un-
der non-reducing conditions and immunorecognition was
performed with anti-APE1 anti-GST antibodies. In both
cases was demonstrated the formation of a high-molecular
weight band accounted for the presence of a complex be-
tween the two proteins (Figure 1B, lane 2) that was lost in
samples treated with DTT (lane 3).
Data from the literature identify the Cys55 of Mia40 as
the catalytically active residue responsible for the disulfide
bond formation with its substrates (18). To determine if
APE1 also formed a mixed disulfide bridge with Mia40
through this residue, GST pull-down assays were performed
comparing APE1’s binding activity of rGST-Mia40-WT
with that of rGST-Mia40 C55S mutant form (Figure 1C).
The mutant Mia40 protein showed a significant reduction
of affinity with APE1 (40 ± 2%) but not a complete loss
of binding as for other Mia40 substrates (22,27). In conclu-
sion, our data demonstrate that Mia40 interacts with APE1
through the formation of a mixed disulfide bridge involving
Mia40 Cys55. Moreover, the partial persistence of interac-
tion even when Cys55 is mutated supports the hypothesis of
a non-covalent contribution to the interactions between the
two proteins.
Cys93 of APE1 is essential for disulfide bond formation with
Mia40
GST pull-down experiments were performed to identify
which of APE1 redox cysteine formed a mixed disulfide
bridge with Mia40. We expressed and purified recombi-
nant APE1 single and double cysteine to serine mutants
(C65S, C93S, C99S, C65S+C93S, C65S+C99S) (Supple-
mentary Figure S2). As reported in Figure 2A, the sub-
stitution of APE1 Cys93 and the substitution of both cys-
teine in position 65 and 93 with serine residues completely
abolished the interaction of the two proteins confirming the
residue Cys93 of APE1 to be primarily involved in the disul-
fide bond formation withMia40. The substitution of Cys99
(single and double mutants with Cys65) did not alter the
interaction with Mia40. Interestingly, the substitution of
Cys65 alone determined a stronger interaction with Mia40
than the WT protein (Figure 2A). To further investigate
in vivo the interaction between APE1 and Mia40, we per-
formed PLA assay overexpressingAPE1-FLAGWT,Cys65
and Cys93 to Ser mutants and quantified the interaction
with endogenous Mia40 (Figure 2B). Presence of PLA sig-
nals demonstrated that ectopic APE1 interacted with en-
dogenous Mia40 which is known to be present only in the
mitochondria IMS. As reported in the histogram of Fig-
ure 2B, APE1 C65S had a stronger interaction with Mia40
than the WT protein, while the C93S mutant showed PLA
signals similar to that of the control reaction (Ctrl) where
the primary antibody for Mia40 was omitted. Interestingly,
the stronger interaction of APE1 C65S was not accompa-
nied by more efficient localization of APE1 in mitochon-
drial (6). This behavior is reminiscent of the conditionalmu-
tant mia40-4 in yeast that binds client proteins but is defec-
tive in the completion of their oxidative folding and ulti-
mately their mitochondrial accumulation (16,25).
Mutation of APE1’s Cys93 affects protein stability inducing
mtDNA damage
We evaluated the effect of APE1’s redox-active cysteine
mutation on the stability of the protein, by transiently
transfecting HeLa cells with pCMV 5.1 vectors express-
ing APE1 WT, Cys65, Cys93, Cys99, Cys65+Cys93 and
Cys65+Cys99 to Ser mutants. Expression levels of ectopic
flagged APE1’s mRNA were analyzed by RT-PCR not
showing any major significant differences between the WT
and all mutant forms (Figure 3A). On the contrary, ectopic
flagged APE1 protein levels in total cell extracts revealed
a significant reduction of both the single C93S (33 ± 8%)
and the double C65S+C93S (12 ± 8%) mutants, therefore
supporting a pivotal role of Cys93 for the overall stability
of the protein itself (Figure 3B). Next, we assessed the ef-
fect of the expression of APE1’s C65S and C93S mutants
on the levels of mtDNA damage. To down regulate endoge-
nous APE1’s expression, we transiently transfected HeLa
 at U
niversita' degli Studi di U
dine CISB di Scienze on June 26, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
5456 Nucleic Acids Research, 2015, Vol. 43, No. 11
Figure 1. Mia40 Cys55 is responsible for the binding to APE1. (A) Western blot (top) and relative quantification (bottom) of the affinity purification
analysis of HeLa cells expressing APE1-FLAG and Mia40-HisTag proteins. Control sample (Mock) and APE1-FLAG (IP) were immunoprecipitated
under native conditions from total cell extracts, separated by 12% SDS-PAGE, and analyzed by western blot to evaluate the levels of each interacting
partner by using specific antibodies (anti-APE1, anti-HisTag). Mia40-HisTag protein resulted enriched in IP fraction. (B) GST pull-down assay under
reducing and non-reducing conditions. Fifteen picomoles of recombinant GST-Mia40 protein were used as bait, GST alone as control and APE1 protein
as prey. Interaction between the two proteins was disrupted after treatment with reducing agent (DTT 20mM).Under non-reducing conditions the complex
formed by APE1 and Mia40 is visible and is disrupted when proteins were incubated with DTT. (C) Western blot (left) and relative histogram (right) of
GST pull-down analysis of recombinant APE1 WT protein. GST-Mia40 WT and C55S mutant (5, 10 and 15 pmoles) were used as prey and GST (15
pmoles) alone as control. The binding of APE1 (5, 10 and 15 pmoles) was normalized to the western blotting signal of GST-Mia40 and resulted strongly
decrease by the mutation of Mia40 Cys55 residue.
cells with a pSuper vector coding for an shRNA sequence
that specifically target APE1’s mRNA, as well as a scram-
ble sequence as a control, and re-expressed shRNA resistant
APE1 WT, Cys 93 and Cys56 to Ser mutant forms (Fig-
ure 3C). Then, we evaluated the effect on the stability of
the mtDNA of these mutants by measuring the levels of
mtDNA damage through a Q-PCR assay that allowed us
to calculate the relative number of mtDNA lesions (30). As
reported in the histogram of Figure 3D, down regulation of
APE1 expression led to increased levels of mtDNAdamage,
while the re-expression ofAPE1WT rescued the phenotype.
Remarkably, re-expression of the redox C65S mutant did
not rescue the phenotype, while the C93S mutant showed
even higher levels of mtDNA damage compared to silenced
cells. In conclusion, we proved that APE1’s Cys93 residue is
necessary for the interactionwithMia40, and that themuta-
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Figure 2. APE1 interacts with Mia40 through the redox Cys93 residue. (A) Western blot (top) and relative histogram (bottom) of GST pull-down analysis
of recombinant APE1 (15 pmoles)WT and redox Cys65, Cys93, Cys99, Cys65+Cys93 and Cys65+Cys99 to Ser mutants. GST-Mia40 (15 pmoles) was used
as prey and GST (15 pmoles) alone as control. The binding of APE1 WT and mutants was normalized to the western blotting signal of GST-Mia40. (B)
Representative immunofluorescence images (top) and histogram (bottom) of PLA analysis between ectopic flagged APE1 and endogenous Mia40. HeLa
cells were transiently transfected with pCMV5.1-FLAG vector expressing APE1 WT, Cys65 and Cys93 to Ser mutants. APE1 expression was detected by
using an anti-FLAG antibody (green), while PLA signal are visible as red dots. Control reaction was carried out omitting anti-Mia40 antibody and shows
no or little PLA signal. White bar corresponded to 10 m. Data reported in the histogram accounted for the average number of PLA signals of at least 15
randomly selected cells per condition.
tion of this residue determines the instability of the protein,
inducing a mitochondrial stress condition that finally leads
to the increase of mtDNA damage.
APE1 is required for the repair of mtDNA
To prove that APE1 is necessary for the maintenance of the
mitochondrial genome stability HeLa cells where endoge-
nous expression of APE1 was knocked-down by siRNA
technology in a conditional manner through a doxycycline-
responsive promoterwere used (29). ControlHeLa cells, ob-
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Figure 3. Cys93 mutation alters APE1’s stability increasing mtDNA damage. (A) mRNA and (B) protein expression analysis of APE1 redox mutants in
HeLa cells. Ten micrograms of total cell extracts from HeLa cells expressing APE1 WT or redox mutant were analyzed by western blot to evaluate the
effect of mutation on APE1 stability. Mutation of Cys93 significantly reduces the accumulation of the protein within the cell with respect to the WT form.
Actin was used as loading control to normalize APE1’s signal intensity. (C) Western blot analysis of HeLa cells after endogenous APE1 silencing and
re-expression of APE1 WT, Cys65 or Cys93 to Ser mutant proteins. Endogenous APE1 protein is significantly reduced after transfection while exogenous
APE1WT, C65S and C93S proteins are expressed. Actin was used as loading control. (D) mtDNA damage analysis of HeLa cells after endogenous APE1
loss of expression and re-expression of ectopic APE1 WT, Cys65 or Cys93 to Ser mutant proteins. Silencing of APE1 leads to increased levels of mtDNA
damage rescued by the re-expression of APE1 WT. APE1 C65S and C93S proteins are not able to rescue the damage after APE1 silencing.
tained after stable transfection with a scrambled sequence
(Scr-1), or silenced HeLa cells bearing the APE1 specific
siRNAplasmid (shRNA), were treated with doxycycline for
10 days, mitochondria were isolated, and expression levels
of APE1 were evaluated by western blotting analysis. As re-
ported in Figure 4A, APE1mitochondrial expression in the
shRNA expressing clone was strongly reduced, with protein
levels less than 10% compared to the control. The endonu-
clease activity was also significantly reduced (Figure 4B).
The levels of mtDNA damage in the HeLa cell model upon
APE1 knock down were then measured, and interestingly,
lack of APE1 in shRNA expressing cells was sufficient to
strongly increase the mtDNA damage under basal condi-
tions (white bars) (Figure 4C). Moreover, when cells were
treated with H2O2 (gray bars) the mtDNA damage was sig-
nificantly increased in shRNA expressing clone with respect
to control. Altogether, our data support the essential role of
APE1 for the repair of oxidative lesions and the repair of
mtDNA.
Mia40 is required for mitochondrial translocation of APE1
Having demonstrated that APE1 interacts with Mia40, the
next step was to test our hypothesis for an active role of
this protein in controlling APE1’s translocation into the mi-
tochondrial IMS. First, Mia40 was overexpressed and the
amount of APE1 within mitochondrial fractions was mea-
sured. A slight, but significant increase of the amount of
mitochondrial APE1 formwas observed (Figure 5A). Next,
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Figure 4. Loss of APE1 expression determines increased levels of mtDNA
damage. (A) Western blot analysis of mitochondrial fractions (MCE) from
control (Scr-1, lane 2) and APE1-shRNA stable clones (lane 3). APE1-
shRNA cells show APE1 reduction up to 90% with respect to the Scr-1
cells. ATP 5A and LSD1 were used as mitochondrial and nuclear mark-
ers, respectively. A nuclear extract (NCE, lane 1) from HeLa cells was
used as control to exclude nuclear/mitochondrial cross contamination.
(B) Endonuclease activity analysis of mitochondrial extracts from Scr-
1 and shRNA cells. The conversion of the fluorescent tetrahydrofuran-
containing oligonucleotide substrate (S) to the shorter incised product (P)
was evaluated for the reported times on a denaturing 20% (wt/vol) poly-
to prove the biological relevance of the MIA pathway in
controlling APE1 mitochondrial translocation, HeLa cells
were transiently transfected with specific siRNA against
Mia40 (Mia40) and the relative scramble control (Ctrl). Sev-
enty two hours upon transfection, cells were harvested, mi-
tochondria and nuclei isolated and the amount of APE1
and Mia40 was evaluated through western blotting anal-
yses. Mia40 levels were significantly reduced (up to 90%)
and consequently, a significant reduction of APE1 levels (35
± 7%) in mitochondria was observed, suggesting a direct
role of Mia40 in controlling APE1’s mitochondrial translo-
cation. On the contrary, no significant variation in APE1’s
nuclear contents was observed (Figure 5B). Then, to ver-
ify if the decrease of APE1 content resulted in a reduction
of mitochondrial endonuclease activity, APE1’s enzymatic
activity on abasic DNA was measured. A tetrahydrofuran
(THF) containing dsDNA probe was incubated with equal
amounts of mitochondrial extracts from Ctrl and Mia40
siRNA-transfected cells for the reported times. A significant
decrease of endonuclease activity was apparent uponMia40
knock down due to the reduction of APE1 amount in the
mitochondrial fraction (Figure 5C). To further support the
physiological relevance of Mia40 in controlling APE1 traf-
ficking, we measured the level of mtDNA damage inMia40
siRNA-transfected cells, and under basal conditions, loss
of Mia40 expression did not significantly affect mtDNA
damage levels. However, when cells were treated with H2O2,
the degree of damage was significantly increased, suggest-
ing that the reduction in mitochondrial APE1 amount, due
to the loss of Mia40, affected the mtDNA repair capabil-
ity and thus sensitizing cells to oxidative damaging agents
(Figure 5D). The same experiment was performed on the
human hepatocellular carcinoma (HCC) cell line JHH6, by
measuring the level of mtDNA damage in Mia40 siRNA-
transfected cells upon H2O2 treatment. The data obtained
were consistent with the previous results on the HeLa cell
line, therefore supporting the generality of the mechanism
(Figure 5D). Overall, these data demonstrate, for the first
time, a direct role of the Mia40 protein in the import of
APE1 into the mitochondrial compartment and its indirect
role in controlling the stability of mtDNA upon oxidative
damage.
Loss of Mia40 expression sensitizes JHH6 hepatic cells to
MMS and H2O2 treatments
APE1’s extra-nuclear localization is a marker of poor prog-
nosis in different cancers, such as hepatocarcinoma (31).
However, up to now, the role of this aberrant localization
in tumor progression has been unknown. In order to deter-
minewhether a correlation exists betweenMia40 expression
levels and the amount of mitochondrial APE1 protein form
in tumor cells, subcellular fractionation was performed on
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
acrylamide gel. A representative image (top) and average values of incision
percentage ±SD of three independent experiments (bottom) are shown.
Endonuclease activity is almost abolished upon loss of APE1 expression.
(C) mtDNA damage analysis of Scr-1 and shRNA clones under basal con-
ditions and after H2O2 treatment (400M). Levels of mtDNAdamage are
increased in cells lacking APE1 both under basal and oxidative stress con-
ditions.
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Figure 5. Loss of Mia40 expression reduces mitochondrial APE1 content affecting mtDNA stability. (A) Western blot analysis (top) of mitochondrial
extracts from HeLa cells overexpressing Mia40-HisTag. HeLa cells were transiently transfected with pCMV 5.1 empty vector (Mock) or codifying for
Mia40-HisTag protein. Densitometric analysis of mitochondrial APE1 levels (bottom) highlights a statistically significant increase of APE1 content into
the mitochondrial fraction as a consequence of Mia40 overexpression. Data are the mean ± SD of three independent experiments. (B) Western blot
analysis of nuclear (NCE) and mitochondrial (MCE) HeLa cell extracts of Mia40 siRNA cells (top). Densitometric analysis of mitochondrial and nuclear
APE1 levels (bottom) highlights a statistically significant reduction of APE1 content into the mitochondrial fraction as a consequence of Mia40 loss of
expression. Data are the mean ± SD of five independent experiments. (C) Endonuclease activity analysis of mitochondrial fractions from scramble (Ctrl)
andMia40-siRNA-treated cells (siRNA). Data analysis reported in the diagram (bottom) shows that endonuclease activity is reduced afterMia40 silencing.
(D) mtDNA damage analysis from HeLa cells (top) and JHH6 hepatic cell line (bottom) after Mia40 loss of expression under basal conditions and after
H2O2 treatment (HeLa: 400 M; JHH6: 1.2 mM). Silencing of Mia40 leads to an increase of mtDNA damage under oxidative stress conditions.
 at U
niversita' degli Studi di U
dine CISB di Scienze on June 26, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015, Vol. 43, No. 11 5461
Figure 6. Loss of Mia40 expression sensitizes JHH6 cells to MMS and H2O2 treatment. (A) Western blot analysis of total (WCE), cytoplasmic (CCE),
nuclear (NCE) and mitochondrial (MCE) cell extracts from JHH6 (lanes 1–4) and Huh7 (lanes 5–8) cell lanes (top). Densitometric analysis shows a direct
correlation between expression levels of Mia40 and APE1 (bottom). ATP 5A and LSD1 were used as mitochondrial and nuclear markers, respectively. (B)
MTS cell viability assay on JHH6 and Huh7 cell lines after 8 h of treatment with increased amounts of MMS shows an increased sensitivity of Huh7 to the
treatment. (C) Western blot analysis of mitochondrial extracts of Mia40 siRNA and relative control from JHH6 cells. Loss of Mia40 expression negatively
affects the mitochondrial levels of APE1 protein. (D) MTS cell viability assay on control (Ctrl) and Mia40 siRNA JHH6 cells after 8 h of treatment with
reported amounts of MMS (top) and H2O2 (bottom). Reduction of mitochondrial APE1 content as a consequence of Mia40 silencing sensitizes cells to
oxidative and alkylating treatments.
two hepatoma cell lines in which we previously demon-
strated that the expression levels of APE1 were significantly
different, particularly in the cytoplasmic compartment (31):
Huh7 (well-differentiated HCC) and JHH6 (poorly differ-
entiated HCC). Western blot analyses highlighted the ex-
istence of a direct correlation between the expression lev-
els of Mia40 and the amount of APE1 in the mitochon-
drial fraction of JHH6 cell extracts (Figure 6A). To ascer-
tain that the increased mitochondrial localization of APE1
was associated with increased resistance to genotoxic dam-
age, both cell lines were treated with increasing amounts
of the DNA alkylating agent MMS and cell viability was
measured upon 8 h of treatment. As reported in Figure 6B,
JHH6 cells were significantly more resistant to the MMS-
treatment than Huh7 cells. The contribution of Mia40 to
the increased resistance observed in JHH6 cells was verified.
Down regulation of Mia40 expression by siRNA transfec-
tion in JHH6 cells caused a significant reduction of mito-
chondrial APE1’s levels (Figure 6C) and a concomitant in-
creased sensitivity to MMS and H2O2 treatments than seen
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in the control cells (Figure 6D). In conclusion, our data
support the general hypothesis for an unexpected role of
the MIA pathway in chemoresistance by directly control-
ling APE1 translocation into mitochondria and therefore
influencing the stability of mtDNA upon genotoxic dam-
age.
DISCUSSION
In this study, we investigated the role played by the inter-
action between Mia40 and the DNA repair protein APE1:
specifically its control over the translocation into the mi-
tochondrial compartment and the involvement of the pro-
tein transport pathway, MIA, in the maintenance of the mi-
tochondrial genome stability. Previously, altered expression
levels and aberrant localization have been demonstrated to
correlate with tumor aggressiveness and chemoresistance
(32–38) but the mechanisms responsible for the unusual
phenotype have never been investigated in detail. As a con-
sequence of its abnormal expression and localization, and
due to its essential role in repairing DNA lesions generated
by chemotherapeutic agents, APE1 is an intriguing can-
didate for novel therapeutic strategies aimed at inhibiting
DNA repair as an effective adjuvant treatment in cancer
therapy. Data reported in the literature concerning APE1
trafficking are still scanty and in some cases contradic-
tory. In this work, we filled this gap and depicted a new
model involving the MIA pathway that may explain how
APE1 is translocated into the mitochondrial IMS. Several
data reported in the literature demonstrate that APE1 is
present within the mitochondria of mammalian cells in its
full-length form (6,8,9), therefore excluding the hypothe-
sis that involvement of a proteolytic process is responsible
for the NLS removal and the re-directioning of APE1 into
the mitochondrion (7). The mitochondrial targeting signal
of APE1 has been identified in the region spanning the
residues 289–318 where Lys299 and Arg301 are the critical
sites so that, if mutated, they completely abolish APE1 mi-
tochondrial translocation under oxidative stress conditions
(9). Previous studies have also shown that APE1 translo-
cates into themitochondria IMS,mainly through the TOM-
dependent pathway, but detailed mechanisms have not yet
been proposed (9). Our data demonstrate that upon passage
through the TOM channel, Mia40 is able to interact and
bind APE1 by forming a disulfide bridge between APE1’s
Cys93 and Mia40’s Cys55 residues (Figure 1 B and C).
Through GST pull-down (Figure 2A) and PLA (Figure 2B)
experiments, we demonstrated that mutation of Cys93 com-
pletely abolished the interaction with Mia40. Moreover,
while mutating Cys65 to Ser, we observed an increased in-
teraction between the two proteins. This could be explained
when taking into account that when Cys65 alone is mu-
tated, Mia40 is able to bind APE1’s Cys93 residue but can-
not complete the reaction because of the lack of the second
cysteine (Cys65), necessary for the disulfide bond forma-
tion. To further evaluate the relevance of these two cysteine
residues, we substituted endogenous APE1 through RNAi
technology, re-expressed APE1 WT or Cys65 and Cys93 to
Ser mutants (Figure 3C), and measured mtDNA damage.
The WT form was able to rescue the phenotype of APE1’s
silenced cells, while no rescue was observed with the C65S
mutant. Remarkably, expression of C93S mutant exerted a
dominant negative effect leading to even higher levels of
mtDNA damage (Figure 3D).
While the C-termDNA-repair domain of APE1 is highly
conserved among different species, the N-term redox do-
main is unique to mammals and has been acquired dur-
ing phylogenetic evolution (39). Through its redox domain,
APE1 exerts its activity by reducing key cysteine residues
of a number of important transcription factors involved
in both cell survival processes and apoptosis induction. In
the N-term domain three cysteine residues (65, 93 and 99)
are present. The current crystallographic structure was ob-
tained in 1997 using a recombinant protein missing the first
35 N-terminal amino acids (40). The Cys65 is absolutely
required for redox activity on nuclear transcriptional fac-
tors but, in this model, it appears as a buried residue, and
therefore APE1 should undergo a local or a more exten-
sive remodeling process to expose the Cys65 to the surface
for the interaction with TFs (41). Cys99 is exposed on the
surface of the protein but its substitution has no effect on
redox activity. Cys93 is also a buried residue and before the
determination of the crystal structure of APE1, it was pro-
posed that Cys65 and 93may form a disulfide bond (42). In-
deed, in the crystallographic structure of APE1, Cys65 and
Cys93 are positioned on opposite sides of a  sheet with a
distance of >8 A˚ apart and therefore a substantial confor-
mational change in the structure of the protein would be
required for the occurrence of a proper disulfide bond for-
mation between these residues (42). Future studies are re-
quired to investigate APE1 structure and structural changes
but it is likely that APE1 is a multifunctional dynamic pro-
tein that, in vivo, may adopt different structural conforma-
tions to fulfill its activities.
In a previous work, we demonstrated that the majority
of APE1 protein accumulates within the IMS and that mu-
tation of Cys65 residues leads to reduced mitochondrial
APE1 localization (6). Here, we showed that Mia40 is in-
volved in the transport of APE1 into the IMS. However,
a portion of APE1 is further translocated, through a still
unidentified mechanism, to the matrix where the mtDNA
resides.
Thismode of translocationwas shown to exist forMrp10,
a subunit of themitochondrial ribosome, which is located in
the matrix and crosses the IMS interacting withMia40 (43).
This protein presents conserved cysteine residues that are
oxidized by Mia40 during import. The semifolded protein
with one disulfide bond is able to pass the inner membrane
to localize in the matrix. Conversely, if Mia40 is silenced the
protein in the matrix is only partially folded and degraded
because it is not able to be assembled in the ribosomes (43).
To assess the physiological relevance of the proposed im-
port mechanism, we determined the contribution of the
MIA pathway in the stability of mtDNA by correlating the
expression levels of Mia40 with the mitochondrial APE1
content. Data obtained highlighted that overexpression of
Mia40 inHeLa cells led to increased levels of mtAPE1 (Fig-
ure 5A). Conversely, the loss of Mia40 expression led to a
significant reduction of mtAPE1 form (Figure 5B) that sub-
sequently led to accumulation of mtDNA damage as a con-
sequence of oxidative stress induction (Figure 5D). There-
fore, our data clearly support a direct involvement ofMia40
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in controlling APE1 translocation into the mitochondria
and, consequently, in the stability of mtDNA. Also the tu-
mor suppressor protein p53 was found to localize within
human mitochondria through the MIA pathway. Authors
demonstrated that the import is an active process activated
by oxidative stress, respiration-dependent, and that it con-
tributes to the maintenance of mtDNA integrity (28).
Cytoplasmic relocalization of APE1 has been found to
be associated with a higher tumor aggressiveness and a
poorer prognosis for the patient in HCC (31). Because
Mia40 was also found to be upregulated in some tumors
(44), we decided to analyze APE1 and Mia40 expression
levels in two HCC cell lines with different degree of differ-
entiation. Higher expression levels of Mia40 in the HCC
poorly differentiated JHH6 cell line correlated positively
with augmented levels of mitochondrial APE1 (Figure 6A)
and, consequently, were associated with an increased re-
sistance to alkylating agent -treatment with respect to the
well-differentiated Huh7 cell line (Figure 6B). Also in this
case, alteration of Mia40 expression and activity in JHH6
cells upon silencing determined a reduction of mitochon-
drial APE1 content which resulted in an increased cellular
sensitivity to alkylating and oxidative stress (Figure 6D).
Alkylating antineoplastic agents are lipophilic bearing posi-
tive charges and therefore tend to accumulate within themi-
tochondria and generate alkylation lesions onmtDNAwith
a 10-fold higher ratio with respect to nDNA (45). APE1
translocates into mitochondria increasing mtDNA repair
rate and therefore, in our model, increased expression of
Mia40 could lead to the promotion of cell survival.
In summary, our data strongly support the hypothesis for
a redox-assisted mechanism dependent on Mia40 in con-
trolling APE1 translocation within mitochondria. Several
questions, in particular how the protein is translocated to
the matrix compartment, are still open and will require fur-
ther studies. However, our findings open new translational
perspectives for cancer treatment based on the use of in-
hibitors of APE1/Mia40 interaction as adjuvant to DNA
damaging chemotherapeutic agents.
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